BlueOcean NutraSciences Inc.

BlueOcean NutraSciences Inc.

August 21, 2015 10:35 ET

BlueOcean NutraSciences Inc.'s Pure Polar XR Product Named 2015 CPG Editor's Choice Award Finalist by Informa's SupplySide

TORONTO, ONTARIO--(Marketwired - Aug. 21, 2015) -

Editors Note: There are two images associated with this press release.

BlueOcean NutraSciences Inc. (TSX VENTURE:BOC) ("BlueOcean" or the "Company"), a nutraceutical company focused on developing specialty oils and extended release (XR) Omega3 oil tablets from shrimp, fish, krill and algae oil for Health and Wellness markets, is pleased to announce that its new Product Pure Polar XR has been Named Among Top CPG Products for Innovation and Market Impact.

Five consumer packaged goods (CPG) products were selected from hundreds of entries by the SupplySide editorial team for achievements in innovation and market impact in 17 different categories. BlueOcean's Pure Polar XR was named to the short list in the Heart Health category. One winner in each category will be announced at SupplySide West 2015, during the SupplySide CPG Editor's Choice Awards Presentations, set for October 7 and 8, in Las Vegas, Nevada.

"This is a great honor and validation of the efforts we have been making at BlueOcean to bring innovative oils and extended release tablet formulations and ingredients to the supplement markets," said BlueOcean CEO, Gavin Bogle.

For more almost 20 years, SupplySide has helped dietary supplement, food, beverage, personal care and cosmetic professionals find information to explore, discover, innovate and market their next best-selling product.

"In the past few years we've had tremendous success highlighting the products that are coming to market, driven by the innovative ingredients highlighted at SupplySide," said Heather Granato, vice president, content, in Informa's Health & Nutrition Network. "In considering hundreds of products, our team narrowed the field based on the unique positioning and ability to serve consumers with truly cutting-edge products."

Mr. Bogle added, "This achievement was made possible by leveraging our differentiating and patent protected bulk shrimp oil products with drug formulator and JV partner CMAX Technologies Inc. ("CMAX") to create extended release Astaxanthin and Omega3 shrimp oil tablets, now commercially available. In addition, I am pleased to announce that at our August 19, 2015, Annual General Meeting of Shareholders, the shareholders voted to elect Management's slate of Directors including a new addition, Vincent Scalisi.

"Vincent is the founder and CEO of Inbox Fitness, and has over 25 years of experience in fitness and media, including as president of the Weider Publications group that produced Men's Fitness, Muscle & Fitness, FLEX, and Muscle & Fitness Hers magazines; chief marketing officer of Iovate Health Sciences (makers of MuscleTech, Hydroxycut and other top supplement brands), and editor in chief of Muscle & Fitness magazine. Vincent is a fan of all-things-fitness, a patented inventor and industrial design enthusiast."

"I am also pleased to announce the hiring of Brian Wolf as a marketing contractor for BlueOcean. Brian will lead BlueOcean's Tablet and Gelcap marketing efforts. Brian has an extensive history in the supplement industry taking strategic initiatives from start to profitable finish. For more than a decade Brian was the Director of Sales - Vitamin & Health US at Iovate," added Mr. Bogle.

About BlueOceanNutraSciences Inc.

BlueOcean is a Canadian listed public company that is focused on developing sustainable, specialty nutraceutical oil products targeted at the rapidly growing Natural Astaxanthin, Omega3 and Algal oil health and wellness markets.

BlueOcean and its 50% JV partner, CMAX, have developed a process to convert shrimp, krill, algae and other fish oils into Extended Release Tablets.

The natural oils to be used in BlueOcean's products contain high levels of naturally occurring astaxanthin, phospholipids, and omega3 EPA and DHA. AstaShrimp™ will be targeted at the high value and rapidly growing natural astaxanthin market. AlgaOmega™ oil is vegetarian, non-GMO omega3 algal oil containing high levels of EPA with Polar Lipids and is targeted at the rapidly growing omega3 algal oil ingredient market. The extended release tablets target the rapidly growing omega3 consumer market and astaxanthin consumer dietary supplements markets.

Forward Looking Statements

This news release may contain forward-looking statements that are based on BlueOcean's expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the images associated with this press release, please visit the following links:

Contact Information

  • BlueOcean NutraSciences Inc.
    Gavin Bogle

    BlueOcean NutraSciences Inc.
    Dil Vashi
    Director of Corporate Development